期刊文献+

体外免疫吸附对狼疮肾炎的治疗和保护作用 被引量:2

Therapeutic and protective effects of extracorporeal immunoadsorption on lupus nephritis
原文传递
导出
摘要 目的 观察体外免疫吸附(EIA) 对狼疮肾炎(LN) 的治疗和肾脏保护作用。方法 比较树脂型EIA、大剂量激素和CTX联合治疗( 简称EIA组)与大剂量激素和CTX治疗( 简称对照组) 血IgG、ANA、dsDNA、C3、24 小时尿蛋白、BUN、Scr 及其他临床指标的变化。结果 治疗2 周时,EIA组血IgG、ANA、dsDNA显著低于对照组[ 两组分别为IgG(10-03 ±2-91) 、(13-54 ±3-05)g/L,ANA(14-00 ±13-14)、(31-82 ±30-02)titer- 1,dsDNA(8-30 ±4-83) 、(27-00 ±18-51) %] 。C3 显著回升[ 两组分别为(587-3±97-03) 、(481-5±132-04)mg/L],24 小时尿蛋白、BUN、Scr 显著低于对照组[ 两组分别为24 小时尿蛋白(2-28±2-07) 、(5-98 ±3-34)g/24h,BUN(9-17 ±2-83)、(15-29 ±5-38)mmol/L、Scr(156-75 ±89-33)、(247-14±74-69)μmol/L) 。治疗4 周时,EIA 组血IgG、dsDNA 仍低于对照组[ Objective To investigate the therapeutic and renal protective effects of resin type extracorporeal immunoadsorption (EIA) on lupus nephritis (LN).Methods Blood levels of IgG, dsDNA antibody, C 3, urine protein of 24 hours, BUN,creatinine and other clinical indexes were compared in EIA, high dose steroid, cyclophosphamide (CTX) therapy (EIA group) with those in high dose steroid, CTX therapy (control group).Results After 2 weeks of therapy, the levels of IgG, ANA, dsDNA antibody were lower markedly in EIA group than those in control group [IgG (10 03±2 91/13 54±3 05)g/L,ANA (14 00±13 14/31 82±30 02)titer -1 ,dsDNA(8 30±4 83/27 00±18 51)% respectively]. The level of C 3 was higher in EIA group[(587 30±97 03/481 50±132 04)mg/L]. The levels of 24 hours urine protein, BUN, serum creatinine were lower markedly in EIA group[24 hours urine protein(2 28±2 07/5 98±3 34)g/24 h,BUN(9 17±2 83/15 29±5 38)mmol/L,Scr (156 75±89 33/247 14±74 69)μmol/L respectively]. After 4 weeks of therapy, the levels of IgG, dsDNA were lower markedly in EIA group than those in control group [IgG (8 92±2 75/11 00±2 28)g/L,dsDNA(9 45±4 96/13 09±5 94)% respectively]. The levels of 24 hours urine protein, BUN, serum creatinine were lower in EIA group [24 hours urine protein (1 03±0 65/1 57±0 83)g/24 h、BUN (7 28±2 33/8 98±2 40)mmol/L、Scr(134 05±78 93/184 95±73 13)μmol/L respectively]. Conclusion Resin type EIA could selectively clear IgG type dsDNA antibody from patient’s blood of lupus nephritis, reduce deposition of immune complex in kidney.EIA in combination with high dose steroid and CTX therapy to lupus nephritis can enhance therapeutic effect, relieve renal lesion and have protective effect of renal function.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 1999年第6期361-364,共4页 Chinese Journal of Nephrology
关键词 狼疮肾炎 治疗 免疫吸附 Lupus nephritis Treatment Immunoadsorption
  • 相关文献

参考文献7

二级参考文献3

  • 1吴名先,临床荟萃,1992年,7卷,193页
  • 2谢尚葵,中华医学杂志,1995年,75卷,617页
  • 3叶任高,肾脏病诊断与治疗学,1994年

共引文献50

同被引文献42

  • 1Belak M, Borberg H, Jimenez C, et al. Therapeutical and Clinical Experience with Protein A Immunoadsouption Columns.Transfus Sci, 1994,15 : 419.
  • 2Huestis D. W, Morrison F. S. Adverse Clinical Effects of immune Sorption With Staphylococcal Protein A Columns. Transfusion Medicine Reviews, 1996,10: 62.
  • 3Fennelly DW, Norton L, Sznol M, et al. A phase Ⅱ trial of extraeorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.Cancer, 1995,75: 2099.
  • 4Rabitsch W, Knobl P, Prinz E, et al, Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stern cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption. Bone Marrow Transplant, 2003,32:1015.
  • 5Appel JZ, Hartwig MG, Davis RD, et al. Utility of Peritransplant and Rescue Intravenous Immunoglobulin and Extracorporeal inImmunoadsorption Lung Transplant Recipients Sensitized to HLA Antigens. Hum Immunol,2005,66:378.
  • 6Esnault VL, Besnier D, Testa A, et al. Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies. J Am Soc Nephrol, 1999,10:2014.
  • 7Esnault VL, Besnier D, Testa A, et al. Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies. J Am Soc Nephrol, 1999,10 : 201 4.
  • 8Mistry B, Kimmel PL, Hetzel PC, et al. The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome. Am J Kidney Dis, 2004,44:50.
  • 9Nilsson IM, Berntorp E, Rickard KA. Results in three Australian haemogpilia B patients with high-responding inhibitors treated with the Malm? model. Haemophilia, 1995,1:59.
  • 10Berta E, Confalonieri P, Simoncini O, et al. Removal of antiacetylcholine recepter antibodies by protein A immunoadsorption in myasthia gravis. Int J Artific Org, 1994,17:603.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部